| Authors: |
Roberts R; ApconiX, Macclesfield SK10 4TG, UK; Department of Biosciences, University of Birmingham, Edgbaston B15 1TT, UK., Blinova K; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US. Food and Drug Administration, Silver Spring, MD USA., Carlson C; FUJIFILM Cellular Dynamics, Inc., Madison, WI, USA., Cato M; GSK, Collegeville, PA, USA., Czysz K; FUJIFILM Cellular Dynamics, Inc., Madison, WI, USA., Feaster TK; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US. Food and Drug Administration, Silver Spring, MD USA., Han X; Department of Electronics, Graduate School of Engineering, Tohoku Institute of Technology, 35-1 Yagiyama Kasumicho, Taihaku-ku, Sendai 982-8577, Japan., Ishibashi Y; Department of Electronics, Graduate School of Engineering, Tohoku Institute of Technology, 35-1 Yagiyama Kasumicho, Taihaku-ku, Sendai 982-8577, Japan., Kanda Y; Division of Pharmacology, National Institute of Health Sciences (NIHS) Japan., Kreir M; Johnson and Johnson Innovative Medicine, 2340 Beerse, Belgium., Levesque P; Bristol-Myers Squib, NJ, USA., Miyamoto N; Eisai, Tsukuba, Japan., Pierson JB; Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: jpierson@hesiglobal.org., Shafer TJ; Shafer Neurotox Consulting, LLC, Durham, NC USA., Schachtele S; FUJIFILM Cellular Dynamics, Inc., Madison, WI, USA., Strock C; Cyprotex, Watertown, USA., Yoshinaga T; Eisai, Tsukuba, Japan., Suzuki I; Department of Electronics, Graduate School of Engineering, Tohoku Institute of Technology, 35-1 Yagiyama Kasumicho, Taihaku-ku, Sendai 982-8577, Japan. |
